(Q43670532)

25 November 2017

title

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp. (English)

1 reference

25 November 2017

1 reference

1 reference

Campylobacter jejuni

1 reference

3

Jones RN

1 reference

25 November 2017

Rhomberg PR

1

1 reference

25 November 2017

Biedenbach DJ

series ordinal

2

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Diagnostic Microbiology and Infectious Disease

25 November 2017

published in

1 reference

25 November 2017

volume

40

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

45-49

1 reference

In vitro activity of new quinolones against Clostridium difficile

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Comparative antianaerobic activity of BMS 284756

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900247-4

7 January 2021

10.1016/S0732-8893(01)00247-4

Identifiers

DOI

1 reference

25 November 2017

1 reference